Shukla Sath has filed 15 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 751407 shares of Spero Therapeutics, Inc. ($SPRO) on February 03, 2025.
Activity breakdown: 0 open-market purchases and 11 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2025 | Spero Therapeutics, Inc. | $SPRO | Shukla Sath | CEO & President | A | Common Stock | 751407 | $0.00 | 1,892,216.0000 | 0 | 65.87% | 0.00% |
| Feb. 5, 2025 | Spero Therapeutics, Inc. | $SPRO | Shukla Sath | CEO & President | S | Common Stock | 6139 | $0.78 | 1,886,077.0000 | 0 | 0.32% | 0.00% |
| Feb. 5, 2025 | Spero Therapeutics, Inc. | $SPRO | Shukla Sath | CEO & President | S | Common Stock | 42786 | $0.78 | 1,843,291.0000 | 0 | 2.27% | 0.00% |
| Feb. 5, 2025 | Spero Therapeutics, Inc. | $SPRO | Shukla Sath | CEO & President | S | Common Stock | 106408 | $0.78 | 1,736,883.0000 | 0 | 5.77% | 0.00% |
| Aug. 27, 2024 | Spero Therapeutics, Inc. | $SPRO | Shukla Sath | CEO & President | S | Common Stock | 2757 | $1.35 | 1,140,809.0000 | 0 | 0.24% | 0.00% |
| Aug. 2, 2024 | Spero Therapeutics, Inc. | $SPRO | Shukla Sath | CEO and President | S | Common Stock | 14800 | $1.32 | 1,161,207.0000 | 0 | 1.26% | 0.00% |
| Aug. 5, 2024 | Spero Therapeutics, Inc. | $SPRO | Shukla Sath | CEO and President | S | Common Stock | 17641 | $1.31 | 1,143,566.0000 | 0 | 1.52% | 0.00% |
| Feb. 1, 2024 | Spero Therapeutics, Inc. | $SPRO | Shukla Sath | CEO and President | A | Common Stock | 679501 | $0.00 | 1,252,001.0000 | 0 | 118.69% | 0.00% |
| Feb. 2, 2024 | Spero Therapeutics, Inc. | $SPRO | Shukla Sath | CEO and President | S | Common Stock | 30901 | $1.37 | 1,221,100.0000 | 0 | 2.47% | 0.00% |
| Feb. 5, 2024 | Spero Therapeutics, Inc. | $SPRO | Shukla Sath | CEO and President | S | Common Stock | 45093 | $1.45 | 1,176,007.0000 | 0 | 3.69% | 0.00% |
| Aug. 28, 2023 | Spero Therapeutics, Inc. | $SPRO | Shukla Sath | CEO and President | S | Common Stock | 1854 | $1.26 | 576,663.0000 | 0 | 0.32% | 0.00% |
| Aug. 29, 2023 | Spero Therapeutics, Inc. | $SPRO | Shukla Sath | CEO and President | S | Common Stock | 4163 | $1.30 | 572,500.0000 | 0 | 0.72% | 0.00% |
| Aug. 1, 2023 | Spero Therapeutics, Inc. | $SPRO | Shukla Sath | CEO and President | A | Common Stock | 266000 | $0.00 | 578,517.0000 | 0 | 85.12% | 0.00% |
| Feb. 1, 2023 | Spero Therapeutics, Inc. | $SPRO | Shukla Sath | Chief Financial Officer | A | Common Stock | 265957 | $0.00 | 322,021.0000 | 0 | 474.38% | 0.00% |
| Feb. 2, 2023 | Spero Therapeutics, Inc. | $SPRO | Shukla Sath | Chief Financial Officer | S | Common Stock | 9504 | $1.83 | 312,517.0000 | 0 | 2.95% | 0.00% |